Parameter | Median PFS or OS time (95% CI)a, months | HR | 95% CIa | 1-sided p-value | |
---|---|---|---|---|---|
Pemetrexed/BSC (n = 28) | BSC (n = 27) | ||||
Maintenance Phase d | |||||
PFS | 3.2 (2.9 to 6.1) | 3.2 (2.2 to 4.3) | 0.76b | 0.42 to 1.37b | 0.1815b |
0.65c | 0.35 to 1.20c | 0.08465c | |||
OS | 12.2 (5.6 to 20.6) | 11.8 (6.3 to 25.6) | 1.13b | 0.56 to 2.28b | 0.36195b |
0.95c | 0.46 to 1.97c | 0.4497c | |||
Overall Study Period (induction + maintenance) e | |||||
PFS | 6.2 (6.0 to 8.3) | 6.0 (4.6 to 6.9) | 0.71b | 0.40 to 1.26b | 0.12325b |
0.60c | 0.33 to 1.09c | 0.0461c | |||
OS | 15.4 (8.4 to 23.7) | 16.4 (9.1 to 28.5) | 1.18b | 0.59 to 2.38b | 0.3188b |
1.01c | 0.49 to 2.08c | 0.48985c |